Automated True Out of Pocket (TrOOP) Balance Transfer (ATBT) Financial Information Reporting (FIR) Update
Relevant to: Medicare-Medicaid Plans (MMPs), PDPs, PACE, 1876, MA
Contract Year (CY) 2024 Part D Pricing Data Submission Guidance
Relevant to: All Part D Plans
Definition of Marketing
Relevant to: Medicare Advantage Organizations, Medicare Advantage-Prescription Drug Plans, Prescription Drug Plan Sponsors, and Section 1876 Cost Plans In order to ensure Medicare beneficiaries are making enrollment decisions based on up-to-date and accurate information, the Centers for Medicare & Medicaid Services (CMS) is issuing this memo to clarify the definition of marketing for Medicare Advantage-Prescription …
Final Medicare Part D DIR Reporting Guidance for 2022
Relevant to: All Medicare Advantage Organizations
Release of the Contract Year (CY) 2024 Bid Submission Functionality in HPMS
Relevant to: All Medicare Advantage Organizations
Instructions for Requesting Drug Manufacturer Access in the Health Plan Management System (HPMS)
Relevant to: All Medicare Advantage Organizations
Deadline for Submitting Risk Adjustment Data for Use in Risk Score Calculation Runs for Payment Years 2022, 2023, 2024 and 2025
Relevant to: All Medicare Advantage Organizations
Dual Eligible Special Needs Plan “Look-Alike” Transitions for Contract Year 2024
Relevant to: Current Medicare Advantage Organizations with a Contract Year 2023 Dual Eligible Special Needs Plan (D-SNP) “Look-Alike” Plan This memorandum provides Medicare Advantage (MA) organizations and section 1876 cost plan sponsors serving individuals dually eligible for Medicare and Medicaid with additional guidance on the obligation to refund any payments of excess cost sharing. See …
Dual Eligible Special Needs Plan “Look-Alike” Transitions for Contract Year 2024 Read More »
NOTICE: April Drug Manufacturer Call on Implementation of IRA Medicare Provisions
Relevant to: All Organization Types and Stakeholders This memorandum provides Medicare Advantage (MA) organizations and section 1876 cost plan sponsors serving individuals dually eligible for Medicare and Medicaid with additional guidance on the obligation to refund any payments of excess cost sharing. See the full guidance for more information.